Cargando…
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
BACKGROUND: Self-regulation of payment disclosure by pharmaceutical industry trade groups is a major global approach to increasing transparency of financial relationships between drug companies and healthcare professionals and organisations. Nevertheless, little is known about the relative strengths...
Autores principales: | Ozieranski, Piotr, Saito, Hiroaki, Rickard, Emily, Mulinari, Shai, Ozaki, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985252/ https://www.ncbi.nlm.nih.gov/pubmed/36869318 http://dx.doi.org/10.1186/s12992-022-00902-9 |
Ejemplares similares
-
Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018) -
Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020) -
Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
por: Ozieranski, Piotr, et al.
Publicado: (2023) -
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
por: Pashley, Dylan, et al.
Publicado: (2022) -
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
por: Ozieranski, Piotr, et al.
Publicado: (2019)